samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

MBE for Boss of Pioneering Sustainable Pharma Packaging Firm

WoolCool



The Managing Director of a pioneering company that manufacturers sustainable packaging for the pharmaceutical industry has been awarded an MBE in the Queen’s Birthday Honours.



Now Josie Morris, Managing Director of Staffordshire-based eco-packaging firm Woolcool, says she hopes the award will ‘help strengthen the growing status of sustainable alternatives, particularly natural materials, in pharma packaging’.

Woolcool produces sustainable temperature-controlled packaging used in the pharmaceutical and healthcare sectors – with customers including Unilever, Henry Schein, Co-op, Baxter Healthcare and the NHS.

The 34-year-old has been awarded an MBE for services to manufacturing and the environment.

She said: “When I received the email from the Cabinet Office I thought it was spam. I thought recognition such as an MBE was for people who are much further along in their career and who have achieved much more than I have.

"Once I realised that it was the real thing, I was blown away. It’s a real honour."

Woolcool manufactures a range of temperature-controlled packaging products, using 100% real sheep’s wool as an insulator instead of manmade alternatives such as polystyrene.



As a natural fibre wool is recyclable, compostable, reusable, biodegradable and abundant and Woolcool’s research – working with institutions such as Cambridge University – proves that it outperforms manmade alternatives.

Josie said: “Packaging has been put in the spotlight by concerns over sustainability, but the industry has taken huge steps in recent years to address the ecological challenges we face.

“Because of the nature of pharma products, the sector has understandably high expectations when it comes to the performance of temperature-controlled packaging, but our research, carried out over more than a decade, shows that there are viable sustainable options available.

“I feel very lucky to have been given this recognition, but I also hope it helps strengthen the growing status of sustainable alternatives, particularly natural materials, in pharma packaging.”

Woolcool is the first packaging company of its kind in the UK to have gained B Corp certification, joining a worldwide community of firms who have pledged to put social and environmental impact on the same level as profitability.

Josie said: “We never claim to be perfect, we are far from it. However, we strive to continually monitor and seek to improve our impact on the planet and people around us. We try to be as transparent in our dealings as possible and, while there is an environmental ethos at our core, we also believe that looking after our people is key to all that we do.

“The success of Woolcool is down to the collaborative approach we take to our work, whether that’s our own team or the broader family of clients, suppliers, customers or partners.”

The Woolcool concept was invented in early 2000s by packaging design pioneer Angela Morris. After working tirelessly to challenge the status quo and open minds to the possibilities of natural materials, she founded the company in 2009 – Josie joined in 2014 in the sales and marketing department, progressing to MD not long after and picking up the Woolcool baton. Now the firm is set to move into bigger premises in Staffordshire.

She said: “We have an amazing team here at Woolcool, and this MBE is for everyone. “I am so proud of the way that our team has coped throughout the and all of the effort that they – and my sister, Jess – have put in to make Woolcool a success.

"So, I would like to say a massive thank you to everyone who has supported and assisted me in the growth of Woolcool, I can’t wait to celebrate all of our achievements with a party when we can."
phone +44 (0)1785 262030
email sales@woolcool.com
web www.woolcool.com/pharma/
email Walton Industrial Estate, 11-12 Beacon Rd, Stone ST15 0NN
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Takara Bio Enters into a License and Supply Agreement of RetroNectin® with BioNTech Cell & Gene Therapies GmbH

Kusatsu/Shiga, Japan – June 24, 2021 – Life Science Newswire – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech"), a BioNTech SE company (www.BioNTech.de), Germany, under which Takara Bio grants BioNTech a commercial license to use applicable patents relating to RetroNectin®.
More info >>


White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement